Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis. (Record no. 21651334)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02169 a2200577 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516083920.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201207s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1524-4539 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1161/CIRCULATIONAHA.111.081125 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Lindman, Brian R |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20120710 |
245 00 - TITLE STATEMENT | |
Title | Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Circulation |
Date of publication, distribution, etc. | May 2012 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 2353-62 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aortic Valve Stenosis |
General subdivision | diagnostic imaging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Blood Pressure |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Compliance |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cyclic Nucleotide Phosphodiesterases, Type 5 |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phosphodiesterase 5 Inhibitors |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Piperazines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pulmonary Circulation |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Purines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Severity of Illness Index |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sildenafil Citrate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Stroke Volume |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sulfones |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ultrasonography |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vascular Resistance |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ventricular Function, Left |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ventricular Function, Right |
General subdivision | drug effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zajarias, Alan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Madrazo, José A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shah, Jay |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gage, Brian F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Novak, Eric |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Johnson, Stephanie N |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chakinala, Murali M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hohn, Tara A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Saghir, Mohammed |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mann, Douglas L |
773 0# - HOST ITEM ENTRY | |
Title | Circulation |
Related parts | vol. 125 |
-- | no. 19 |
-- | p. 2353-62 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1161/CIRCULATIONAHA.111.081125">https://doi.org/10.1161/CIRCULATIONAHA.111.081125</a> |
Public note | Available from publisher's website |
No items available.